Covid-19 Vaccine Act According to World Health Experts and Institutes

Irma Rachmawati Maruf, Sardjana Orba Manullang, Hotmaria Hertawaty Sijabat, Sitti Asnaeni. Am, Ali Pirdaus

Abstract


This paper aims to obtain authentic scientific evidence about the status of the Covid-19 vaccination regulations from experts from both world health organizations and various institutions concerned with vaccination and pandemic issues. We obtained data to support this study from an electronic search for national and international health journals that focus on vaccination and preventing conflict in future meetings. We conducted in-depth studies and tests to turn off the data that we found answered the problem of this study wholly and validly. This study obtains secondary data from the evidence of previous scientific studies with a phenomenological approach, namely the exploration of accurate and accurate data to obtain valid answers. Based on the evidence and discussion of this data exposure, we can conclude that the vaccination law is a recommendation from the government to provide services against various threats caused by this pandemic, which is a recommendation that must be submitted persuasively and accurately. Thus, these findings become supporting data for further studies in the future.


Keywords


Covid-19; vaccination; health; experts, institutions

Full Text:

PDF

References


Abdulla, Z. A., Al-Bashir, S. M., Al-Salih, N. S., Aldamen, A. A., & Abdulazeez, M. Z. (2021). A summary of the SARS-CoV-2 vaccines and technologies available or under development. Pathogens, 10(7), 788.

Arthi, V., & Parman, J. (2021). Disease, downturns, and wellbeing: Economic history and the long-run impacts of COVID-19. Explorations in Economic History, 79, 101381.

Balasubramanian, M. (2020). Covid 19-the new age pandemic Notion Press.

Bibbins-Domingo, K., Petersen, M., & Havlir, D. (2021). We are taking a vaccine to where the virus is—equity and effectiveness in coronavirus vaccinations. Paper presented at the JAMA Health Forum, 2(2) e210213-e210213.

Bish, A., Yardley, L., Nicoll, A., & Michie, S. (2011). Factors associated with uptake of vaccination against pandemic influenza: A systematic review. Vaccine, 29(38), 6472-6484.

Blake, P. G., Hladunewich, M. A., & Oliver, M. J. (2021). COVID-19 vaccination imperatives in people on maintenance dialysis: An international perspective. Clinical Journal of the American Society of Nephrology: CJASN, 16(11), 1746-1748. doi:10.2215/CJN.07260521 [doi]

Christensen, L. B., Johnson, B., Turner, L. A., & Christensen, L. B. (2011). Research methods, design, and analysis.

Corlett, R. T., Primack, R. B., Devictor, V., Maas, B., Goswami, V. R., Bates, A. E., . . . Roth, R. (2020). Impacts of the coronavirus pandemic on biodiversity conservation. Biological Conservation, 246, 108571. doi:10.1016/j.biocon.2020.108571 [doi]

Damjanov, I., Perry, A. M., & Perry, K. (2021). Pathology for the health professions-E-book Elsevier Health Sciences.

Dhama, K., Sharun, K., Tiwari, R., Dadar, M., Malik, Y. S., Singh, K. P., & Chaicumpa, W. (2020). COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Human Vaccines & Immunotherapeutics, 16(6), 1232-1238.

Dhillon, P., Altmann, D., & Male, V. (2021). COVID‐19 vaccines: What do we know so far? The FEBS Journal, 288(17), 4996-5009.

Dinis-Oliveira, R. J. (2020). COVID-19 research: Pandemic versus "paperdemic," integrity, values, and risks of the "speed science."Forensic Sciences Research, 5(2), 174-187.

Djalante, R., Shaw, R., & DeWit, A. (2020). Building resilience against biological hazards and pandemics: COVID-19 and its implications for the Sendai framework. Progress in Disaster Science, 6, 100080.

Edelman, C. L., Kudzma, E. C., & Rnc, D. M. (2021). Health promotion throughout the life span-e-book Elsevier Health Sciences.

Edwards, D. J. (2021). Ensuring effective public health communication: Insights and modeling efforts from theories of behavioral economics, heuristics, and behavioral analysis for decision making under risk. Frontiers in Psychology, 12.

Elo, S., Kääriäinen, M., Kanste, O., Pölkki, T., Utriainen, K., & Kyngäs, H. (2014). Qualitative content analysis: A focus on trustworthiness. SAGE Open, 4(1), 2158244014522633.

Erdem, O., Eş, I., Saylan, Y., & Inci, F. (2021). Unifying the efforts of medicine, chemistry, and engineering in biosensing technologies to tackle the challenges of the COVID-19 pandemic. Analytical Chemistry.

Fakhruddin, B. S., Blanchard, K., & Ragupathy, D. (2020). Are we there yet? The transition from response to recovery for the COVID-19 pandemic. Progress in Disaster Science, 7, 100102.

Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S.,.. Clutterbuck, E. A. (2020). Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomized controlled trial. The Lancet, 396(10249), 467-478.

Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., . . . Clutterbuck, E. A. (2020). Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomized controlled trial. The Lancet, 396(10249), 467-478.

Giampaolo, N. (2021). Regretting Vaccine Indecision: Solving Covid-19 Vaccine Hesitancy through Anticipated Regret-Nudging.

Glick, B. R., & Patten, C. L. (2017). Molecular biotechnology: Principles and applications of recombinant DNA John Wiley & Sons.

Gostin, L. O. (2020). COVID-19 reveals the urgent need to strengthen the world health organization. Paper presented at the JAMA Health Forum, 1(4) e200559-e200559.

Hendren, S. (2020). What can a body do?: How we meet the built world Penguin.

Javed, S., & Chattu, V. K. (2020). Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy. Health Promotion Perspectives, 10(4), 300.

Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020). Immunological considerations for COVID-19 vaccine strategies. Nature Reviews Immunology, 20(10), 615-632.

Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., . . . Song, S. (2020). Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature, 584(7819), 115-119.

Kaur, S. P., & Gupta, V. (2020). COVID-19 vaccine: A comprehensive status report. Virus Research, 198114.

Kennedy, A., LaVail, K., Nowak, G., Basket, M., & Landry, S. (2011). Confidence about vaccines in the United States: Understanding parents’ perceptions. Health Affairs, 30(6), 1151-1159.

Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N., & Sriwastava, S. (2021). Acute transverse myelitis following SARS-CoV-2 vaccination: A case report and literature review. Journal of Neurology, 1-12.

Liu, Y., Salwi, S., & Drolet, B. C. (2020). Multivalue ethical framework for fair global allocation of a COVID-19 vaccine. Journal of Medical Ethics, 46(8), 499-501. doi:10.1136/med ethics-2020-106516 [doi]

Loehr, J. (2020). Communicating about immunizations. Prim Care, 47, 419-430.

Mackey, A., & Gass, S. M. (2015). Second language research: Methodology and design Routledge.

Manullang, S.O., 2021. Giving COVID-19 vaccines to citizens: Understanding legal basis. Int. J. Health Sci. 364–372.

Markwell, A., Mitchell, R., Wright, A. L., & Brown, A. F. (2020). Clinical and ethical challenges for emergency departments during communicable disease outbreaks: Can lessons from ebola virus disease be applied to the COVID‐19 pandemic? Emergency Medicine Australasia, 32(3), 520-524.

McGee, E. O. (2021). Black, brown, bruised: How racialized STEM education stifles innovation Harvard Education Press.

Modgil, S., Gupta, S., & Bhushan, B. (2020). Building a living economy through modern information decision support systems and UN sustainable development goals. Production Planning & Control, 31(11-12), 967-987.

Narayanan, L., Pandit, M., Basu, S., Karmakar, A., Bidhan, V., Kumar, H., & Brar, K. (2020). Impact of lockdown due to COVID-19 outbreak: Lifestyle changes and public health concerns in India.

Naser, M., Mohamed, M., & Shehata, L. H. (2021). Advanced strategies against COVID 19 review. International Journal of Progressive Sciences and Technologies, 26(1), 395-412.

Nashef, H. A. (2020). Giving a face to the silenced victims: Recent documentaries on Gaza. Quarterly Review of Film and Video, 1-19.

Nasirin, C., & Lionardo, A. (2020). The nurse's role in educating the prevention of transmission of the covid-19: A study on improving the healthy living among urban communities. International Journal of Pharmaceutical Research, 12(2).

Ningrum, P. A., et al. (2020). The Potential of Poverty in the City of Palangka Raya: Study SMIs Affected Pandemic Covid 19. Budapest International Research and Critics Institute-Journal (BIRCI-Journal) Volume 3, No 3, Page: 1626-1634

Novick, T. K., Rizzolo, K., & Cervantes, L. (2020). COVID-19 and kidney disease disparities in the United States. Advances in Chronic Kidney Disease, 27(5), 427-433.

Oreskes, N. (2015). The fact of uncertainty, the uncertainty of facts, and the cultural resonance of doubt. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 373(2055), 20140455.

Paul, E., Steptoe, A., & Fancourt, D. (2021). Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health-Europe, 1, 100012.

QASIM, Q. A., HUSSEIN, H. H., SHARI, F. H., AL-SALMAN, H., AHMED, G. S., & JEBER, M. A. (2020). General study: The effect of corpulence and persistent sicknesses on the seriousness of the diseases with covid-19. International Journal of Pharmaceutical Research, 12(3).

Rahiem, M. D. (2020). University students' emergency remote learning experience in Indonesia amidst the COVID-19 crisis. International Journal of Learning, Teaching and Educational Research, 19(6), 1-26.

Roe, E., Veal, C., & Hurley, P. (2019). Mapping microbial stories: Creative microbial aesthetic and cross‐disciplinary intervention in understanding nurses’ infection prevention practices. Geo: Geography and Environment, 6(1).

Saleh, A., Mujahiddin. (2020). Challenges and Opportunities for Community Empowerment Practices in Indonesia during the Covid-19 Pandemic through Strengthening the Role of Higher Education. Budapest International Research and Critics Institute-Journal (BIRCI-Journal). Volume 3, No 2, Page: 1105-1113.

Salmon, D. A., Dudley, M. Z., Glanz, J. M., & Omer, S. B. (2015). Vaccine hesitancy: Causes, consequences, and a call to action. Vaccine, 33, D66-D71.

Schoch-Spana, M., Brunson, E. K., Long, R., Ruth, A., Ravi, S. J., Trotochaud, M., . . . Connell, N. (2021). The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine, 39(40), 6004-6012.

Shanmugaraj, B., & Phoolcharoen, W. (2021). Addressing the demand for recombinant biopharmaceuticals in the COVID-19 era. Asian Pacific Journal of Tropical Medicine, 14(2), 49.

Shaw, C. A. (2021). The age of COVID-19: Fear, loathing, and the "New Normal ."International Journal of Vaccine Theory, Practice, and research, 1(2), 98-142.

Shekhar, R., Sheikh, A. B., Upadhyay, S., Singh, M., Kottewar, S., Mir, H., . . . Pal, S. (2021). COVID-19 vaccine acceptance among health care workers in the united states. Vaccines, 9(2), 119.

Sihombing, E. H., Nasib. (2020). The Decision of Choosing Course in the Era of Covid 19 through the Telemarketing Program, Personal Selling and College Image. Budapest International Research and Critics Institute-Journal (BIRCI-Journal) Volume 3, No. 4, Page: 2843-2850.

Tanriover, M. D., Doğanay, H. L., Akova, M., Güner, H. R., Azap, A., Akhan, S., . . . Tabak, Ö. F. (2021). Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): Interim Results of a double-blind, randomized, placebo-controlled, phase 3 trial in turkey. The Lancet, 398(10296), 213-222.

Trogen, B., Oshinsky, D., & Caplan, A. (2020). Adverse consequences of rushing a SARS-CoV-2 vaccine: Implications for public trust. Jama, 323(24), 2460-2461.

Uddin, M., Mustafa, F., Rizvi, T. A., Loney, T., Al Suwaidi, H., Al-Marzouqi, A. H. H., . .. Stefanini, C. (2020). SARS-CoV-2/COVID-19: Viral genomics, epidemiology, vaccines, and therapeutic interventions. Viruses, 12(5), 526.

Walker, P. G. T., Whittaker, C., Watson, O. J., Beguelin, M., Winskill, P., Hamlet, A., . . . Ghani, A. C. (2020). The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science (New York, N.Y.), 369(6502), 413-422. doi:10.1126/science.abc0035 [doi]

Warren, A. M., Sulaiman, A., & Jaafar, N. I. (2014). Social media fosters online civic engagement and builds citizen trust and trust in institutions. Government Information Quarterly, 31(2), 291-301.

Wilson, A. L., Courtenay, O., Kelly-Hope, L. A., Scott, T. W., Takken, W., Torr, S. J., & Lindsay, S. W. (2020). The importance of vector control for the control and elimination of vector-borne diseases. PLoS Neglected Tropical Diseases, 14(1), e0007831.

Wilson, R. J. I., Vergélys, C., Ward, J., Peretti-Watel, P., & Verger, P. (2020). Vaccine hesitancy among general practitioners in southern France and their reluctant trust in the health authorities. International Journal of Qualitative Studies on Health and Well-being, 15(1), 1757336.

Wouters, O. J., Shadlen, K. C., Salcher-Konrad, M., Pollard, A. J., Larson, H. J., Teerawattananon, Y., & Jit, M. (2021). Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. The Lancet.

Wu, S., Huang, J., Zhang, Z., Wu, J., Zhang, J., Hu, H., . . . Fan, P. (2021). Safety, tolerability, and immunogenicity of an aerosolized adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: Preliminary report of an open-label and randomized phase 1 clinical trial. The Lancet Infectious Diseases, 21(12), 1654-1664.

Yaqub, O., Castle-Clarke, S., Sevdalis, N., & Chataway, J. (2014). Attitudes to vaccination: A critical review. Social Science & Medicine, 112, 1-11.

Zhang, J. Y., Shang, T., Ahn, D., Chen, K., Coté, G., Espinoza, J., . . . Wallia, A. (2021). How to best protect people with diabetes from the impact of SARS-CoV-2: Report of the international COVID-19 and diabetes summit. Journal of Diabetes Science and Technology, 15(2), 478-514.

Zhang, J., Zeng, H., Gu, J., Li, H., Zheng, L., & Zou, Q. (2020). Progress and prospects on vaccine development against SARS-CoV-2. Vaccines, 8(2), 153.




DOI: https://doi.org/10.33258/birci.v5i1.3836

Article Metrics

Abstract view : 117 times
PDF - 34 times

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.